Artivion (AORT) Capital Expenditures Growth (1y) (2011 - 2026)
Artivion (AORT) Capital Expenditures Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | -17.56% |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 34.96% |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -5.35% |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 15.89% |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -11.95% |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -47.73% |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 106.98% |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Artivion | 1.25 Bn | 1.19 Bn | 75.45 Mn | 119.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 119.98% |
| Dec 31, 2025 | 1,830.32% |
| Sep 30, 2025 | 26.66% |
| Jun 30, 2025 | 30.80% |
| Mar 31, 2025 | 0.75% |
| Dec 31, 2024 | -46.61% |
| Sep 30, 2024 | 75.97% |
| Jun 30, 2024 | 15.70% |
| Mar 31, 2024 | 27.01% |
| Dec 31, 2023 | -29.60% |
| Sep 30, 2023 | -27.92% |
| Jun 30, 2023 | 19.60% |
| Mar 31, 2023 | 26.98% |
| Dec 31, 2022 | 47.68% |
| Sep 30, 2022 | -12.40% |
| Jun 30, 2022 | -68.40% |
| Mar 31, 2022 | 49.07% |
| Dec 31, 2021 | 19.01% |
| Sep 30, 2021 | 134.77% |
| Jun 30, 2021 | 364.59% |